Literature DB >> 6268825

Alterations to controls of cellular DNA synthesis by adenovirus infection.

A W Braithwaite, J D Murray, A J Bellett.   

Abstract

Human adenovirus type 5 and temperature-sensitive mutants ts36, ts37, and ts125 induced cellular DNA synthesis in quiescent rodent cells at both permissive and nonpermissive temperatures. Cellular DNA synthesis induced by adenovirus type 5 or by serum required protein synthesis for both initiation and continuation, whereas viral DNA synthesis was not dependent upon continued protein synthesis once it was initiated. Both cellular and viral DNA replication was induced in adenovirus type 5-infected cells in the presence of dibutyryl cyclic AMP at concentrations which inhibited induction by serum which suggested that some of the controls of DNA synthesis in serum-treated and virus-infected cells are different. After adenovirus infection of quiescent cells, there was a decrease in the number of cells with G1 DNA content and an increase in cells with G2 diploid and greater DNA contents. Thus, adenovirus type 5 induces a complete round of cellular DNA replication, but in some cells, it induces a second round without completion of a normal mitosis. These results suggest that adenovirus type 5 is able to alter cell growth cycle controls in a way which may be related to its ability to transform cells.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6268825      PMCID: PMC171341     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  29 in total

1.  Genetic analysis of human adenovirus type 5 in permissive and nonpermissive cells.

Authors:  J F Willians; C S Young; P E Austin
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1975

2.  Cell transformation: a study of regulation with types 5 and 12 adenovirus temperature-sensitive mutants.

Authors:  H S Ginsberg; M J Ensinger; R S Kauffman; A J Mayer; U Lundholm
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1975

3.  Studies on in vitro transformation by DNA and DNA fragments of human adenoviruses and simian virus 40.

Authors:  F L Graham; P J Abrahams; C Mulder; H L Heijneker; S O Warnaar; F A De Vries; W Fiers; A J Van Der Eb
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1975

4.  Inhibition of adenovirus type 12 induced DNA synthesis in G1-arrested BHK21 cells by dibutyryl adenosine cyclic 3':5'-monophosphate.

Authors:  J E Zimmerman; K Raska
Journal:  Nat New Biol       Date:  1972-10-04

5.  Cell growth and the initiation of transformation by SV40.

Authors:  G J Todaro; H Green
Journal:  Proc Natl Acad Sci U S A       Date:  1966-02       Impact factor: 11.205

6.  A restriction point for control of normal animal cell proliferation.

Authors:  A B Pardee
Journal:  Proc Natl Acad Sci U S A       Date:  1974-04       Impact factor: 11.205

7.  Mature form of the deoxyribonucleic acid from chick embryo lethal orphan virus.

Authors:  H B Younghusband; A J Bellett
Journal:  J Virol       Date:  1971-09       Impact factor: 5.103

8.  An adenovirus type 5 gene function required for initiation of viral DNA replication.

Authors:  P C Vliet; J S Sussenbach
Journal:  Virology       Date:  1975-10       Impact factor: 3.616

9.  Synthesis of type 2 adenovirus DNA in the presence of cycloheximide.

Authors:  M S Horwitz; C Brayton; S G Baum
Journal:  J Virol       Date:  1973-04       Impact factor: 5.103

10.  Interactions of adenovirus type 2 with rat embryo cells. Permissiveness, transformation and in vitro characteristics of adenovirus transformed rat embryo cells.

Authors:  P H Gallimore
Journal:  J Gen Virol       Date:  1974-11       Impact factor: 3.891

View more
  25 in total

Review 1.  Does the antitumor adenovirus ONYX-015/dl1520 selectively target cells defective in the p53 pathway?

Authors:  B R Dix; S J Edwards; A W Braithwaite
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

2.  Ability of p53 and the adenovirus E1b 58-kilodalton protein to form a complex is determined by p53.

Authors:  A W Braithwaite; J R Jenkins
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

3.  Relationship between organization of the actin cytoskeleton and the cell cycle in normal and adenovirus-infected rat cells.

Authors:  P Jackson; A J Bellett
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

4.  Replication properties of human adenovirus in vivo and in cultures of primary cells from different animal species.

Authors:  Christian Jogler; Dennis Hoffmann; Dirk Theegarten; Thomas Grunwald; Klaus Uberla; Oliver Wildner
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

5.  Adenovirus type 2 activates cell cycle-dependent genes that are a subset of those activated by serum.

Authors:  H T Liu; R Baserga; W E Mercer
Journal:  Mol Cell Biol       Date:  1985-11       Impact factor: 4.272

6.  Ubiquitin-dependent proteolysis of cyclin D1 is associated with coxsackievirus-induced cell growth arrest.

Authors:  Honglin Luo; Jingchun Zhang; Frank Dastvan; Bobby Yanagawa; Michael A Reidy; Huifang M Zhang; Decheng Yang; Janet E Wilson; Bruce M McManus
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

Review 7.  The structure and functions of the adenovirus early region 1 proteins.

Authors:  R J Grand
Journal:  Biochem J       Date:  1987-01-01       Impact factor: 3.857

8.  Expression of adenovirus E1B mutant phenotypes is dependent on the host cell and on synthesis of E1A proteins.

Authors:  E White; B Stillman
Journal:  J Virol       Date:  1987-02       Impact factor: 5.103

9.  An adenovirus early region 1A protein is required for maximal viral DNA replication in growth-arrested human cells.

Authors:  K R Spindler; C Y Eng; A J Berk
Journal:  J Virol       Date:  1985-03       Impact factor: 5.103

10.  Adenovirus-induced alterations of the cell growth cycle: a requirement for expression of E1A but not of E1B.

Authors:  A W Braithwaite; B F Cheetham; P Li; C R Parish; L K Waldron-Stevens; A J Bellett
Journal:  J Virol       Date:  1983-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.